CyageniCyagen
HomeAI Assistant
Toolbox
Databases
Resources
About Us
AI Tools
RNA Splicer
ASO Designer
Pathogenicity Predictor
Bioinfo Tools
Sequence Viewer
Mutation Direct
Antibody Discovery
Target Insights
Computational Analysis
Databases
Gene Database
Disease Database
Model Database
Mutation Database
Learn
Learning Center
Explore
iCyagen
Cyagen
OriCellTM
AbSeekTM
Contact
Contact Us
EN
中文
Home
Learn
ASO User Guide

ASO User Guide

2026-07-30 | ASO development team
ASO
ASO Designer is a cutting-edge, AI-powered tool tailored for the precision design of Antisense Oligonucleotides (ASOs). The tool leverages state-of-the-art deep learning architectures to assist researchers in identifying optimal sequences for Exon Skipping, Exon Inclusion, and mRNA Degradation.
Tool Introduction and Background

ASO Designer is a cutting-edge, AI-powered tool tailored for the precision design of Antisense Oligonucleotides (ASOs). The tool leverages state-of-the-art deep learning architectures to assist researchers in identifying optimal sequences for Exon Skipping, Exon Inclusion, and mRNA Degradation.

ASO Designer integrates two specialized engine modules to ensure high-accuracy predictions:

  • OligoAI [1] (for mRNA Degradation): Built upon RiNALMo [2] (Ribonucleic Acid Language Model), a 33-layer Transformer-based "giga-scale" model. It predicts inhibition efficiency (%) by encoding the ASO sequence alongside its pre-mRNA context, accounting for chemical modifications and experimental conditions.
  • ASO-ExonPred (for Splicing Modulation): Specifically designed for splice-switching [3] ASOs. It utilizes a CNN-Transformer hybrid architecture (inspired by SpliceTransformer [4]) trained on genomic-scale data. It integrates multiple biophysical features, including RNA secondary structure via RNAstructure [5], hybridization thermodynamics via OligoWalk [6], and off-target risk assessment via BLAT [7].
Detailed Operating Steps
1. Choose Your Mechanism

At the top of the page, select the strategy based on your therapeutic goal:

  • Exon Skipping: Facilitates the "skipping" of a specific target exon during splicing.
  • Exon Inclusion: Promotes the retention of a target exon in the final mRNA transcript.
  • mRNA Degradation: Targets mRNA for breakdown using mechanisms like RNase H-dependent gapmers.
choose-mechanismism
2. Set Up Your Parameters
Enter your data in the "Parameters" panel on the left side of the screen.
A. For Exon Skipping and Exon Inclusion
  • Gene Name: Enter the official human gene symbol. The system will provide suggestions as you type.
  • Transcript: Select a specific transcript (RefSeq NM_ or Ensembl ENST_ [8]). Note: Different transcripts may have different exon numbering and coordinates.
  • Target Exon:
    • Exon Numbers: Choose the exon you wish to target from the dropdown.
    • Exon Coordinate: Manually input the exact start/end coordinates if needed.
  • ASO Length: Select the desired length (standard range is 12–30nt; default is 20nt).
  • Mutation (Optional): Enter mutations using HGVS nomenclature (e.g., c.1234G>A). This allows the AI to predict efficiency within a specific variant background.
exon-inclusion
B. For mRNA Degradation
  • Sugar Modifications: Enter the pattern for sugar-ring modifications (e.g., 5xMOE, 10xDNA, 5xMOE). Supported types: MOE, DNA, cEt.
  • Backbone Modifications: Define the linkage chemistry (e.g., 19xPS). Supported types: PS (Phosphorothioate), PO (Phosphodiester).
  • Transfection Method & Dosage: Select the delivery method (e.g., Electroporation, Gymnosis, Lipofection) and set the dosage (default is 4000nM).
mRNA-degradation
3. Run the Design
  • Click the【Design】button to start the AI calculation. It usually takes between 10 and 30 seconds to get your results.
  • You can click【Reset】at any time to clear all fields.
mRNA-degradation
4. Review Results
The review process depends on the mechanism you chose:
A. For Exon Skipping and Exon Inclusion
  • Table: View the top 10 recommended sequences and their Splicing Scores.
  • Scatter Plot: Check the visual map for performance. Aim for high-scoring dots and avoid red dots marked as "Exon Off-Target" risks.
exon-inclusion
B. For mRNA Degradation:
  • Pick a Transcript: After the calculation finishes, check the box next to one or more transcripts in the structure map to load their specific data.
  • Review Indicators: Once a transcript is selected, a detailed list will appear below showing the Genomic Coordinate, Region (Exonic/Intronic), and the AI Score.
  • Filter: Higher scores indicate better predicted degradation efficiency.
mRNA-degradation
5. Export data
Click the [Download] button to save the full candidate list as a CSV file, including detailed metrics like gc_content, tm_value, and prediction_score.
The Science Behind the Scoring
To help you select the best candidates, ASO Designer provides multi-dimensional scoring:
Splicing Modulation Scoring (ASO-ExonPred)

The primary metric is the Weighted Percentile Score (0–100). A higher score indicates a higher probability of successful splicing modulation. The score is a composite of:

  • Splice Model Score: Predicted effect based on the CNN-Transformer model [4].
  • Thermodynamics: Binding affinity calculated via OligoWalk [6].
  • Off-target Penalty: Sequences with high off-target risks (based on BLAT [7] alignment) are penalized.
  • Sequence Constraints: Penalties are applied for extreme GC content or unfavorable Tm values.
Degradation Efficiency (OligoAI [1])
The Prediction Score (0–100) represents the estimated Inhibition %. This model is trained on the ASO Atlas [9] dataset-comprising approximately 188,521 experimental data points-to ensure high correlation with real-world laboratory results.
Key Reminders & Compliance
  • Human Species Only: This tool is currently optimized specifically for human genes.
  • Open Source Disclosure: ASO Designer utilizes and acknowledges the following open-source models and tools: OligoAI [1], RiNALMo [2], RNAstructure [5], OligoWalk [6], and BLAT [7].
  • Experimental Validation: While our AI provides high-confidence rankings, these scores are statistical estimates. We strongly recommend experimental validation before advancing to clinical stages.
References
  • [1] B. Hill et al., *Accurately modelling RNase H-mediated antisense oligonucleotide efficacy*, bioRxiv (2025). https://doi.org/10.1101/2025.10.29.685292; https://www.biorxiv.org/content/10.1101/2025.10.29.685292v1
  • [2] R. J. Penić, M. Šikić, M. Sušanj, *RiNALMo: General-purpose RNA language models can generalize well on structure prediction tasks*, arXiv:2403.00043 (2024). https://arxiv.org/abs/2403.00043
  • [3] Aartsma-Rus, A. (2012). Overview on Aon Design. Methods in Molecular Biology.
  • [4] You, N., et al. (2024). SpliceTransformer predicts tissue-specific splicing linked to human diseases. Nature Communications.
  • [5] Reuter, J. S., & Mathews, D. H. (2010). RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics.
  • [6] Lu, Z. J., & Mathews, D. H. (2008). OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Research.
  • [7] Kent, W. J. (2002). BLAT-the BLAST-like alignment tool. Genome Research.
  • [8] Cunningham, F., et al. (2024). Ensembl 2024. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1049
  • [9] Hill, B. et al. (2025). ASO Atlas: a comprehensive dataset of RNase H antisense oligonucleotides. bioRxiv.
CONTENTS
Tool Introduction and Background
Detailed Operating Steps
1. Choose Your Mechanism
2. Set Up Your Parameters
A. For Exon Skipping and Exon Inclusion
B. For mRNA Degradation
3. Run the Design
4. Analyze Results
A. For Exon Skipping and Exon Inclusion
B. For mRNA Degradation
5. Export and Save Results
The Science Behind the Scoring
Key Reminders & Compliance
References
Cyagen
Home
Tools
Database
Resources
About Us
Email: icyagen-support@cyagen.com
Phone: +86 18620792549
Address: No.98, Xiangxue Road, Huangpu District, Guangzhou City
Follow us on social media
Contact us via LinkedIn
Link: https://www.linkedin.com/company/cyagen-biosciences
Copy
Contact us via YouTube
Link: https://www.youtube.com/@Cyagen
Copy
iCyagen
Copyright © 2024 Cyagen Biosciences. All Rights Reserved.
Privacy Policy
User Agreement
Back to top